Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7889268rdf:typepubmed:Citationlld:pubmed
pubmed-article:7889268lifeskim:mentionsumls-concept:C0028128lld:lifeskim
pubmed-article:7889268lifeskim:mentionsumls-concept:C1801960lld:lifeskim
pubmed-article:7889268lifeskim:mentionsumls-concept:C0264995lld:lifeskim
pubmed-article:7889268lifeskim:mentionsumls-concept:C0036974lld:lifeskim
pubmed-article:7889268lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:7889268lifeskim:mentionsumls-concept:C0277785lld:lifeskim
pubmed-article:7889268lifeskim:mentionsumls-concept:C0680727lld:lifeskim
pubmed-article:7889268lifeskim:mentionsumls-concept:C0679823lld:lifeskim
pubmed-article:7889268pubmed:issue4lld:pubmed
pubmed-article:7889268pubmed:dateCreated1995-4-19lld:pubmed
pubmed-article:7889268pubmed:abstractText1. Splanchnic artery occlusion (SAO) shock is characterized by irreversible circulatory failure. Tumour necrosis factor (TNF-alpha) may affect the L-arginine/nitric oxide (NO) pathway, thus contributing to the cardiovascular derangements of circulatory shock. 2. We investigated the contribution of both TNF-alpha and the L-arginine/nitric oxide pathway to the vascular dysfunction of SAO shock. Anaesthetized rats, subjected to total occlusion of the superior mesenteric artery and the coeliac trunk for 45 min developed a severe shock state (SAO shock) resulting in a fatal outcome within 75-90 min after the release of occlusion. Sham operated animals were used as controls. SAO shocked rats had also a marked hypotension and enhanced macrophage and serum levels of TNF-alpha. Furthermore, aortic rings from shocked rats showed a marked hyporeactivity to phenylephrine (PE 1 nM-10 microM) and reduced responsiveness to acetylcholine (ACh 10 nM-10 microM). Endothelium-denuded aortic rings had also a marked hyporeactivity to phenylephrine, which was restored to control values by in vitro administration of NG nitro-L-arginine-methyl ester (L-NAME 10 microM). 3. In vivo administration of cloricromene (2 mg kg-1, i.v.), an inhibitor of TNF-alpha biosynthesis, increased survival, enhanced mean arterial blood pressure and reduced macrophage and serum levels of TNF-alpha. Furthermore, aortic rings from shocked rats treated with cloricromene exhibited a greater contractile response to phenylephrine and improved responsiveness to ACh when compared to aortic rings from vehicle-treated SAO shocked rats. 4. Our results suggest that TNF-alpha alters both endothelial and muscular L-arginine/nitric oxide pathways which in turn produce vascular dysfunction in SAO shock.lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:languageenglld:pubmed
pubmed-article:7889268pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:citationSubsetIMlld:pubmed
pubmed-article:7889268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7889268pubmed:statusMEDLINElld:pubmed
pubmed-article:7889268pubmed:monthDeclld:pubmed
pubmed-article:7889268pubmed:issn0007-1188lld:pubmed
pubmed-article:7889268pubmed:authorpubmed-author:SquadritoGGlld:pubmed
pubmed-article:7889268pubmed:authorpubmed-author:SaittaAAlld:pubmed
pubmed-article:7889268pubmed:authorpubmed-author:CanalePPlld:pubmed
pubmed-article:7889268pubmed:authorpubmed-author:FerlitoMMlld:pubmed
pubmed-article:7889268pubmed:authorpubmed-author:AltavillaDDlld:pubmed
pubmed-article:7889268pubmed:authorpubmed-author:SquadritoFFlld:pubmed
pubmed-article:7889268pubmed:authorpubmed-author:CampoG MGMlld:pubmed
pubmed-article:7889268pubmed:authorpubmed-author:ZingarelliBBlld:pubmed
pubmed-article:7889268pubmed:authorpubmed-author:IoculanoMMlld:pubmed
pubmed-article:7889268pubmed:authorpubmed-author:AmmendoliaLLlld:pubmed
pubmed-article:7889268pubmed:issnTypePrintlld:pubmed
pubmed-article:7889268pubmed:volume113lld:pubmed
pubmed-article:7889268pubmed:ownerNLMlld:pubmed
pubmed-article:7889268pubmed:authorsCompleteNlld:pubmed
pubmed-article:7889268pubmed:pagination1153-8lld:pubmed
pubmed-article:7889268pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:meshHeadingpubmed-meshheading:7889268-...lld:pubmed
pubmed-article:7889268pubmed:year1994lld:pubmed
pubmed-article:7889268pubmed:articleTitleParticipation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock.lld:pubmed
pubmed-article:7889268pubmed:affiliationInstitute of Pharmacology, School of Medicine, University of Messina, Italy.lld:pubmed
pubmed-article:7889268pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7889268pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:7889268pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7889268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7889268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7889268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7889268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7889268lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7889268lld:pubmed